Lineage Biosciences Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

Lineage Biosciences General Information

Description

Developer of an antibody discovery technology intended to profile antibody responses using sequencing of immunoglobulin genes. The company's technology provides deep analysis of antibodies generated by natural immune responses during infection, autoimmune disease, cancer, immunization and vaccination, enabling the medical industry to develop vaccines and to accelerate antibody discovery.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 3183 Porter Drive
  • Palo Alto, CA 94304
  • United States
Primary Industry
Other Pharmaceuticals and Biotechnology
Acquirer
AbCellera
Corporate Office
  • 3183 Porter Drive
  • Palo Alto, CA 94304
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Lineage Biosciences Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Lineage Biosciences‘s full profile, request access.

Request a free trial

Lineage Biosciences Patents

  • 17

    Total Documents Applications and Grants

  • Total Patents Families

  • 13

    Granted

  • 2

    Pending

  • Expiring in next 12 mo

Lineage Biosciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-2905505-A1 Methods of characterizing the immune repertoire by tagging and sequencing immunoglobulin or t-cell receptor nucleic acids Active 15-Mar-2013
CA-2905505-C Methods of characterizing the immune repertoire by tagging and sequencing immunoglobulin or t-cell receptor nucleic acids Active 15-Mar-2013
EP-2970959-B1 Methods and compositions for tagging and analyzing samples Active 15-Mar-2013
EP-2970958-A2 Methods of sequencing the immune repertoire Active 15-Mar-2013
EP-2970958-B1 Methods of sequencing the immune repertoire Active 15-Mar-2013 B01J19/0046
To view Lineage Biosciences’s complete patent history, request access »

Lineage Biosciences FAQs

  • When was Lineage Biosciences founded?

    Lineage Biosciences was founded in 2014.

  • Where is Lineage Biosciences headquartered?

    Lineage Biosciences is headquartered in Palo Alto, CA.

  • What industry is Lineage Biosciences in?

    Lineage Biosciences’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is Lineage Biosciences a private or public company?

    Lineage Biosciences is a Private company.

  • What is Lineage Biosciences’s current revenue?

    The current revenue for Lineage Biosciences is .

  • When was Lineage Biosciences acquired?

    Lineage Biosciences was acquired on 01-Aug-2018.

  • Who acquired Lineage Biosciences?

    Lineage Biosciences was acquired by AbCellera.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »